Bora vs We Can Medicines: monthly revenue

Monthly revenue and year-on-year change for Bora (6472) and We Can Medicines (6929) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Bora ━ We Can Medicines

0%+59%-30%25/1026/0126/0426/0726/10

Monthly revenue history

MonthBoraYoYWe Can MedicinesYoY
Oct 2026NT$1.99 billion+15.9%NT$284 million+4.5%
Sep 2026NT$2.33 billion+35.1%NT$266.4 million+5.2%
Aug 2026NT$2.18 billion+59.2%NT$275.4 million+2.0%
Jul 2026NT$1.9 billion+5.8%NT$270 million+1.3%
Jun 2026NT$2.3 billion+39.2%NT$257.4 million-4.3%
May 2026NT$2.11 billion+40.2%NT$282.9 million-0.2%
Apr 2026NT$1.48 billion-27.5%NT$262.3 million-0.8%
Mar 2026NT$1.53 billion+6.3%NT$272 million+2.5%
Feb 2026NT$1.33 billion-23.2%NT$260 million+3.8%
Jan 2026NT$1.14 billion-30.2%NT$264.8 million-6.1%
Dec 2025NT$1.66 billion-16.6%NT$272.1 million-2.6%
Nov 2025NT$1.5 billion-10.8%NT$273.6 million+0.7%
Oct 2025NT$1.72 billion-17.8%NT$271.9 million+3.2%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16